Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome.
Cross-linked hyaluronic acid gel occlusive device for the treatment of dry eye syndrome.
Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease
Comparison of 0.2% and 0.18% hyaluronate eye drops in patients with moderate to severe dry eye with keratitis or keratoconjunctivitis
Comparative study of 0.1% hyaluronic acid versus 0.5% carboxymethylcellulose in patients with dry eye associated with moderate keratitis or keratoconjunctivitis
Assessment of dry eye signs and symptoms and ocular tolerance of a preservative-free lacrimal substitute (Hylabak®) versus a preserved lacrimal substitute (Systane®) used for 3 months in patients after LASIK.
Safety, effcacy, and intraoperative characteristics of DisCoVisc and Healon ophthalmic viscosurgical devices for cataract surgery
Systane® lubricant eye drops in the management of ocular dryness
Management of post-LASIK dry eye: a multicenter randomized comparison of a new multi-ingredient artificial tear to carboxymethylcellulose.
Use of viscoelastic substance in ophthalmic surgery – focus on sodium hyaluronate
Use of preservative-free hyaluronic acid (Hylabak (®)) for a range of patients with dry eye syndrome: experience in Russia.